Clinical Trials Logo

Filter by:
NCT ID: NCT01209715 Withdrawn - COPD Clinical Trials

Effect of an Inhaled Glucocorticoid-long-acting Beta Adrenergic Agonist on Endothelial Function in COPD

Start date: October 2010
Phase: Phase 2
Study type: Interventional

In the present study, the investigators wish to address the effect of a glucocorticoid/long-acting beta-agonist preparation on endothelial function in COPD patients who do not currently smoke (ex-smokers) by measuring endothelium-dependent (albuterol response) and endothelium-independent (NTG response) vasodilation in the bronchial artery, reflecting endothelium-dependent and endothelium-independent vasodilation (drug-induced increase in Qaw, ΔQaw). With this approach the investigators will test the hypothesis that in stable ICS-naïve COPD patients, endothelium-dependent vasodilation is restored with a glucocorticoid/long-acting beta-agonist preparation, presumably resulting from the glucocorticoid component.

NCT ID: NCT01207622 Withdrawn - Clinical trials for Attention Deficit Hyperactivity Disorder

Efficacy of Atomoxetine for ADHD in Adolescents and Young Adults With SUD

Start date: n/a
Phase: Phase 4
Study type: Interventional

The primary objective of the study is to investigate the efficacy of Atomoxetine (ATMX) in the treatments of adolescent and young adult Attention Deficit Hyperactivity Disorder (ADHD) with comorbid Substance Use Disorder (SUD). The secondary objective of the study is to determine the efficacy of ATMX in preventing SUD relapse. As previous pre-clinical work has demonstrated that ATMX has led to significant improvement in ADHD in children and lacks abuse liability, the investigators hypothesize that ATMX will be efficacious in treating ADHD in adolescents and young adults with SUD, and that ATMX will also be efficacious in preventing SUD relapse.

NCT ID: NCT01207128 Withdrawn - Aspergillosis Clinical Trials

Trial of Combination Antifungal Therapy (Vori+Mica vs. Vori+Placebo) in Invasive Aspergillosis

Start date: February 2011
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the therapeutic effectiveness of combination antifungal therapy (CAT) of voriconazole plus micafungin versus voriconazole plus placebo equivalent as primary therapy for invasive aspergillosis (IA) in patients with hematological cancer.

NCT ID: NCT01206998 Withdrawn - Labor, Premature Clinical Trials

Vaginal Progesterone as a Treatment for Women Active Preterm Labor

VagPro
Start date: July 2010
Phase: N/A
Study type: Interventional

The purpose of this study is to compare how well vaginal progesterone works delaying the time to delivery in women with preterm labor compared to placebo. The study will also compare the effect of vaginal progesterone on neonatal outcomes, rate of spontaneous preterm delivery, cervical length and biomarkers of preterm delivery in women diagnosed with and treated with medication to stop preterm labor.

NCT ID: NCT01204138 Withdrawn - Clinical trials for Arthritis, Rheumatoid

Concomitant Use of Apremilast for the Treatment of Active RA Despite TNF-Inhibition and Methotrexate- CATARA

CATARA
Start date: September 2010
Phase: Phase 2
Study type: Interventional

A Phase II, single institution, double blind, randomized, placebo controlled, cross-over study exploring the safety and efficacy apremilast in patients with active RA with concomitant use of TNF inhibition. Following a screening period, patients with active disease on stable TNF inhibition will be randomized to receive either apremilast or placebo for a period of 12 weeks. At the end of 12 weeks patients will be assessed for efficacy using the ACR responder index looking for a 20% improvement, then all patients initially randomized and treated in a blinded fashion with apremilast will be crossed over to placebo while those patients initially randomized and treated with placebo will be crossed over to apremilast. Patients will be followed for an additional 12 weeks on treatment to assess both safety and efficacy of this combination treatment. Following 24 weeks of active treatment or early termination, patients will undergo a 28 day safety visit.

NCT ID: NCT01203618 Withdrawn - Clinical trials for Resectable, Non-functioning Pituitary Adenoma

Exploratory Study of Farletuzumab to Treat Resectable, Non-functioning Pituitary Adenomas

Start date: February 2011
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate whether therapy with farletuzumab is effective and safe in the treatment of resectable, non-functioning pituitary adenomas.

NCT ID: NCT01203579 Withdrawn - Lung Cancer Clinical Trials

Chest Computed Tomography (CT) Screening Study With Antibody Testing

Start date: September 2011
Phase: N/A
Study type: Observational

The purpose of this study is to assess the value of EarlyCDT-Lung test and CT scan both in lung cancer detection and potential health economic outcomes.

NCT ID: NCT01202929 Withdrawn - Dysphagia Clinical Trials

Correlation of High Resolution Esophageal Manometry With Symptoms

Start date: February 2010
Phase: N/A
Study type: Observational

High Resolution Manometry is a new technology that utilizes 36 solid state sensors on a thin catheter spaced at 1-cm intervals. One can more effectively measure the pressure of the esophagus. It includes a sophisticated software to display the pressures data as color topography plot using time, length of the esophagus and pressure within the entire esophagus. It is unclear if this technology improvement actually correlates with patient's symptoms.

NCT ID: NCT01202539 Withdrawn - Brain Tumor Clinical Trials

Real-time Assessment of Frameless Intrafraction Motion

Start date: September 2010
Phase:
Study type: Observational

The purpose of this study is to assess the ability of a modified thermoplastic mask system in keeping an individual head stationary for a predefined amount of time. The investigators hope to know if the modified mask is study enough, and also if the modification on the mask will allow the investigator see and track the individual's movement underneath the mask by means of a camera that can detect light reflected from the individual. Participants will lay down on their backs and their heads will be held in place with the mask system for approximately 1 hour.

NCT ID: NCT01202318 Withdrawn - Stroke Clinical Trials

Comparative Evaluation of Stroke Triage Algorithms for Emergency Medical Dispatchers

MeDS
Start date: May 2010
Phase: N/A
Study type: Observational

This study will compare the diagnostic accuracy of Card 28 stroke protocol to Card 28 and Cincinnati Stroke Scale, when used by emergency medical dispatchers to interrogate a 911 call suggestive of stroke. The authors hypothesize that a combination of Card 28 plus the Cincinnati Stroke Scale (CSS) will improve the diagnostic accuracy of emergency medical dispatchers for stroke.